Theranostics: Are we there yet?

Molecular Pharmaceutics

Volumn 10, Issue 3, 2013, Pages 848-856

  Svenson, Sonke ^a  

^a Drug Delivery Solutions LLC   (United States)

Author keywords

diagnostic and therapeutic agents; functionalized polymers; liposomes; nanomedicine; polymeric micelles; polymeric nanoparticles; polymersomes; theranostic nanocarriers

Indexed keywords

DENDRIMER; LIPOSOME; NANOCARRIER; PRODRUG;

LIGAND BINDING; MEMBRANE PERMEABILITY; MICELLE; NANOTECHNOLOGY; PRIORITY JOURNAL; PROBABILITY; REVIEW;

EID: 84874637808     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp300644n     Document Type: Review

References (63)

1. Cancer Nanotechnology-Going Small for Big Advances, NIH Publication No. 04-5489, 2004.
2. Cancer Nanotechnology Plan, NIH Publication No. 11-7794, 2010.
3. Lee, D. Y.; Li, K. C. P. Molecular theranostics: A primer for the imaging professional Am. J. Roentgenol. 2011, 197, 318-324
4. Svenson, S.; Prud'homme, R. K., Eds. Multifunctional Nanoparticles for Drug Delivery Applications; Nanostructure Science and Technology Series; Springer: New York, Dordrecht, Heidelberg, London, 2012.
5. Svenson, S. Clinical Translation of Nanomedicines Curr. Opin. Solid State Mater. Sci. 2012, doi.org/10.1016/j.cossms.2012.10.001
6. Duncan, R.; Gaspar, R. Nanomedicine(s) under the microscope Mol. Pharmaceutics 2011, 8, 2104-2141
7. Bharali, D. J.; Mousa, S. A. Emerging nanomedicines for early cancer detection and improved treatment: Current perspective and future promise Pharmacol. Ther. 2010, 128, 324-335
8. Al-Jamal, W. T.; Kostarelos, K. Liposomes: From a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine Acc. Chem. Res. 2011, 44, 1094-1104
9. Wang, L. S.; Chuang, M. C.; Ho, J. A. Nanotheranostics-A review of recent publications Int. J. Nanomed. 2012, 7, 4679-4695
10. Choi, H. S.; Frangioni, J. V. Nanoparticles for biomedical imaging: Fundamentals of clinical translation Mol. Imaging 2010, 9, 291-310
11. Jokerst, J. V.; Gambhir, S. S. Molecular imaging with theranostic nanoparticles Acc. Chem. Res. 2011, 44, 1050-1060
12. Bae, K. H.; Chung, H. J.; Park, T. G. Nanomaterials for cancer therapy and imaging Mol. Cells 2011, 31, 295-302
13. Mura, S.; Couvreur, P. Nanotheranostics for personalized medicine Adv. Drug Delivery Rev. 2012, 64, 1394-1416
14. Ma, X.; Zhao, Y.; Liang, X. J. Theranostic nanoparticles engineered for clinic and pharmaceutics Acc. Chem. Res. 2011, 44, 1114-1122
15. Caldorera-Moore, M. E.; Liechty, W. B.; Peppas, N. A. Responsive theranostic systems: Integration of diagnostic imaging agents and responsive controlled release drug delivery carriers Acc. Chem. Res. 2011, 44, 1061-1070
16. Fang, C.; Zhang, M. Nanoparticle-based theragnostics: Integrating diagnostic and therapeutic potentials in nanomedicine J. Controlled Release 2010, 146, 2-5
17. Choi, K. Y.; Liu, G.; Lee, S.; Chen, X. Theranostic nanoplatforms for simultaneous cancer imaging and therapy: Current approaches and future perspectives Nanoscale 2012, 4, 330-342
18. Nainani, N.; Panesar, M. Nephrogenic systemic fibrosis Am. J. Nephrol. 2009, 29, 1-9
19. Cacheris, W. P.; Quay, S. C.; Rocklage, S. M. The relationship between thermodynamics and the toxicity of gadolinium complexes Magn. Reson. Imaging 1990, 8, 467-481
20. Shi, J.; Liu, T. W. B.; Chen, J.; Green, D.; Jaffray, D.; Wilson, B. C.; Wang, F.; Zheng, G. Transforming a targeted porphyrin theranostic agent into a PET imaging probe for cancer Theranostics 2011, 1, 363-370
21. Mullen, D. G.; Fang, M.; Desai, A. M.; Baker, J. R.; Orr, B. G.; Banaszak-Holl, M. M. A quantitative assessment of nanoparticle ligand distributions: Implications for targeted drug and imaging delivery in dendrimer conjugates ACS Nano 2010, 4, 657-670
22. Wang, J.; Tian, S.; Petros, R. A.; Napier, M. E.; DeSimone, J. M. The complex role of multivalency in nanoparticles targeting the transferrin receptor for cancer therapies J. Am. Chem. Soc. 2010, 132, 11306-11313
23. Ornelas, C.; Pennell, R.; Liebes, L. F.; Weck, M. Construction of a well-defined multifunctional dendrimer for theranostics Org. Lett. 2011, 13, 976-979
24. Tang, J.; Lobatto, M. E.; Read, J. C.; Mieszawska, A. J.; Fayad, Z. A.; Mulder, W. J. M. Nanomedical theranostics in cardiovascular disease Curr. Cardiovasc. Imaging Rep. 2012, 5, 19-25
25. Caruthers, S. D.; Cyrus, T.; Winter, P. M.; Wickline, S. A.; Lanza, G. M. Anti-angiogenic perfluorocarbon nanoparticles for diagnosis and treatment of atherosclerosis WIREs Nanomed. Nanobiotechnol. 2009, 1, 311-323
26. Choi, K. Y.; Swierczewskla, M.; Lee, S.; Chen, X. Protease-activated drug development Theranostics 2012, 2, 156-178
27. Lee, M. H.; Kim, J. Y.; Han, J. H.; Bhuniya, S.; Sessler, J. L.; Kang, C.; Kim, J. S. Direct fluorescence monitoring of the delivery and cellular uptake of a cancer-targeted RGD peptide-appended naphthalimide theragnostic prodrug J. Am. Chem. Soc. 2012, 134, 12668-12674
28. Santra, S.; Kaittanis, C.; Santiesteban, O. J.; Perez, J. M. Cell-specific, activatable, and theranostic prodrug for dual-targeted cancer imaging and therapy J. Am. Chem. Soc. 2011, 133, 16680-16688
29. Pan, D.; Sanyal, N.; Schmieder, A. H.; Senpan, A.; Kim, B.; Yang, X.; Hu, G.; Allen, J. S.; Gross, R. W.; Wickline, S. A.; Lanza, G. M. Antiangiogenic nanotherapy with lipase-labile Sn-2 fumagillin prodrug Nanomedicine 2012, 7, 1507-1519
30. Soenen, S. J.; Vande Velde, G.; Ketkar-Atre, A.; Himmelreich, U.; De Cuyper, M. Magnetoliposomes as magnetic resonance imaging contrast agents WIREs Nanomed. Nanobiotechnol 2011, 3, 197-211
31. Kamaly, N.; Miller, A. D. Paramagnetic liposome nanoparticles for cellular and tumour imaging Int. J. Mol. Sci. 2010, 11, 1759-1776
32. Béalle, G.; Di Corato, R.; Kolosnjaj-Tabi, J.; Dupuis, V.; Clément, O.; Gazeau, F.; Wilhelm, C.; Ménager, C. Ultra magnetic liposomes for MR imaging, targeting, and hyperthermia Langmuir 2012, 28, 11834-11842
33. Ding, N.; Lu, Y.; Lee, R. J.; Yang, C.; Huang, L.; Liu, J.; Xiang, G. Folate receptor-targeted fluorescent paramagnetic bimodal liposomes for tumor targeting Int. J. Nanomed. 2011, 6, 2513-2520
34. Muthu, M. S.; Kulkarni, S. A.; Raju, A.; Feng, S. S. Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots Biomaterials 2012, 33, 3494-3501
35. Zhang, L. W.; Wen, C. J.; Al-Suwayeh, S. A.; Yen, T. C.; fang, J. Y. Cisplatin and quantum dots encapsulated in liposomes as multifunctional nanocarriers for theranostic use in brain and skin J. Nanopart. Res. 2012, 14, 882-899
36. Strijkers, G. J.; Kluza, E.; Van Tilborg, G. A. F.; van der Schaft, D. W. J.; Griffioen, A. W.; Mulder, W. J. M.; Nicolay, K. paramagnetic and fluorescent liposomes for target-specific imaging and therapy of tumor angiogenesis Angiogenesis 2010, 13, 161-173
37. Li, S.; Goins, B.; Zhang, L.; Bao, A. Novel multifunctional theranostic liposome drug delivery system: Construction, characterization, and multimodality MR, near-infrared fluorescent, and nuclear imaging Bioconjugate Chem. 2012, 23, 1322-1332
38. De Oliveira, H.; Thevenot, J.; Lecommandoux, S. Smart polymersomes for therapy and diagnosis: Fast progress toward multifunctional biomimetic nanomedicines WIREs Nanomed. Nanobiotechnol. 2012, 4, 525-546
39. Tanner, P.; Baumann, P.; Enea, R.; Onaca, O.; Palivan, C.; Meier, W. Polymeric vesicles: From drug carriers to nanoreactors and artificial organelles Acc. Chem. Res. 2011, 44, 1039-1049
40. Sanson, C.; Diou, O.; Thévenot, J.; Ibarboure, E.; Soum, A.; Bruîlet, A.; Miraux, S.; Thiaudieìre, E.; Tan, S.; Brisson, A.; Dupuis, V.; Sandre, O.; Lecommandoux, S. Doxorubicin loaded magnetic polymersomes: Theranostic nanocarriers for MR imaging and magneto-chemotherapy ACS Nano 2011, 5, 1122-1140
41. Yang, X.; Grailer, J. J.; Rowland, I. J.; Javadi, A.; Hurley, S. A.; Steeber, D. A.; Gong, S. Multifunctional SPIO/DOX-loaded wormlike polymer vesicles for cancer therapy and MR imaging Biomaterials 2010, 31, 9065-9073
42. Kaida, S.; Cabral, H.; Kumagai, M.; Kishimura, A.; Terada, Y.; Sekino, M.; Aoki, I.; Nishiyama, N.; Tani, T.; Kataoka, K. Visible drug delivery by supramolecular nanocarriers directing to single-platformed diagnosis and therapy of pancreatic tumor model Cancer Res. 2010, 70, 7031-7041
43. Hu, R.; Law, W. C.; Lin, G.; Ye, L.; Liu, J.; Reynolds, J. L.; Yong, K. T. PEGylated phospholipid micelle-encapsulated near-infrared PbS quantum dots for in vitro and in vivo bioimaging Theranostics 2012, 2, 723-733
44. Kumar, R.; Kulkarni, A.; Nagesha, D. K.; Sridhar, S. In vitro evaluation of theranostic polymeric micelles for imaging and drug delivery in cancer Theranostics 2012, 2, 714-722
45. Pandey, M. K.; Tyagi, R.; Yang, K.; Fisher, R. J.; Colton, C. K.; Kumar, J.; Parmar, V. S.; Aiazian, E.; Watterson, A. C. Design and synthesis of perfluorinated amphiphilic copolymers: Smart nanomicelles for theranostic applications Polymer 2011, 52, 4727-4735
46. Xiao, Y.; Hong, H.; Javadi, A.; Engle, J. W.; Xu, W.; Yang, Y.; Zhang, Y.; Barnhart, T. E.; Cai, W.; Gong, S. Multifunctional unimolecular micelles for cancer-targeted drug delivery and positron emission tomography imaging Biomaterials 2012, 33, 3071-3082
47. Li, X.; Qian, Y.; Liu, T.; Hu, X.; Zhang, G.; You, Y.; Liu, S. Amphiphilic multiarm star block copolymer-based multifunctional unimolecular micelles for cancer targeted drug delivery and MR imaging Biomaterials 2011, 32, 6595-6605
48. Zhang, L.; Lin, Y.; Zhang, Y.; Chen, R.; Zhu, Z.; Wu, W.; Jiang, X. Fluorescent micelles based on star amphiphilic copolymer with a porphyrin core for bioimaging and drug delivery Macromol. Biosci. 2012, 12, 83-92
49. Cabral, H.; Nishiyama, N.; Kataoka, K. Supramolecular nanodevices: Fom design validation to theranostic nanomedicine Acc. Chem. Res. 2011, 44, 999-1008
50. Janib, S. M.; Moses, A. S.; MacKay, J. A. Imaging and drug delivery using theranostic nanoparticles Adv. Drug Delivery Rev. 2010, 62, 1052-1063
51. Fernandez-Fernandez, A.; Manchanda, R.; McGoron, A. J. Theranostic applications of nanomaterials in cancer: Drug delivery, image-guided therapy, and multifunctional platforms Appl. Biochem. Biotechnol. 2011, 165, 1628-1651
52. Kim, K.; Kim, J. H.; Park, H.; Kim, Y. S.; Park, K.; Nam, H.; Lee, S.; Park, J. H.; Park, R. W.; Kim, I. S.; Choi, K.; Kim, S. Y.; Park, K.; Kwon, I. C. Tumor-homing multifunctional nanoparticles for cancer theragnosis: Simultaneous diagnosis, drug delivery, and therapeutic monitoring J. Controlled Release 2010, 146, 219-227
53. Kelkar, S. S.; Reineke, T. M. THeranostics: Combining imaging and therapy Bioconjugate Chem. 2011, 22, 1879-1903
54. Ng, K. K.; Lovell, J. F.; Zheng, G. Lipoprotein-inspired nanoparticles for cancer theranostics Acc. Chem. Res. 2011, 44, 1105-1113
55. Fang, C.; Kievit, F. M.; Veiseh, O.; Stephen, Z. R.; Wang, T.; Lee, D.; Ellenbogen, R. G.; Zhang, M. Fabrication of magnetic nanoparticles with controllable drug loading and release through a simple assembly approach J. Controlled Release 2012, 162, 233-241
56. Ernsting, M. J.; Foltz, W. D.; Undzys, E.; Tagami, T.; Li, S. D. Tumor-targeted drug delivery using MR-contrasted docetaxel- carboxymethylcellulose nanoparticles Biomaterials 2012, 33, 3931-3941
57. Wang, S.; Kim, G.; Koo Lee, Y. E.; Hah, H. J.; Ethirajan, M.; Pandey, R. K.; Kopelman, R. Multifunctional biodegradable polyacrylamide nanocarriers for cancer theranostics-A "see and treat" strategy ACS Nano 2012, 6, 6843-6851
58. Chen, Z.; Penet, M. F.; Nimmagadda, S.; Li, C.; Banerjee, S. R.; Winnard, P. T., Jr.; Artemov, D.; Glunde, K.; Pomper, M. G.; Bhujwalla, Z. M. PSMA-targeted theranostic nanocomplex for prostate cancer therapy ACS Nano 2012, 6, 7752-7762
59. Jung, H.; Park, K. M.; Yang, J. A.; Oh, E. J.; Lee, D. W.; Park, K.; Ryu, S. H.; Hahn, S. K.; Kim, K. Theranostic systems assembled in situ on demand by host-guest chemistry Biomaterials 2011, 32, 7687-7694
60. Nyström, A. M.; Wooley, K. L. The importance of chemistry in creating well-defined nanoscopic embedded therapeutics: Devices capable of the dual functions of imaging and therapy Acc. Chem. Res. 2011, 44, 969-978
61. Liu, Y.; Ghassemi, A. H.; Hennink, W. E.; Schwendeman, S. P. The microclimate pH in poly(D,L-lacyide- co -hydroxymethyl glycolide) microspheres during biodegradation Biomaterials 2012, 33, 7584-7593
62. Perry, J. L.; Herlihy, K. P.; Napier, M. E.; DeSimone, J. M. PRINT: A novel platform toward shape and size specific nanoparticle theranostics Acc. Chem. Res. 2011, 44, 990-998
63. Abeylath, S. C.; Ganta, S.; Iyer, A. K.; Amiji, M. Combinatorial-designed multifunctional polymeric nanosystems for tumor-targeted therapeutic delivery Acc. Chem. Res. 2011, 44, 1009-1017